430
Views
61
CrossRef citations to date
0
Altmetric
Original Article

A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial

, , , , , , , , , , , & show all
Pages 702-708 | Received 11 Jan 2008, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

David Stewart, Farhan Anwar & Gayatri Vedantam. (2020) Anti-virulence strategies for Clostridioides difficile infection: advances and roadblocks. Gut Microbes 12:1.
Read now
Vo Van Giau, Hyon Lee, Seong Soo A An & John Hulme. (2019) Recent advances in the treatment of C. difficile using biotherapeutic agents. Infection and Drug Resistance 12, pages 1597-1615.
Read now
Javier A. Villafuerte Gálvez & Ciarán P. Kelly. (2017) Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection. Expert Review of Gastroenterology & Hepatology 11:7, pages 611-622.
Read now
Russell G. A. Jones & Angela Martino. (2016) Targeted localized use of therapeutic antibodies: a review of non-systemic, topical and oral applications. Critical Reviews in Biotechnology 36:3, pages 506-520.
Read now
Thirumalai Diraviyam, Jin-Xin He, Chen Chen, Bin Zhao, Antonysamy Michael & Xiaoying Zhang. (2016) Effect of Passive Immunotherapy Against Clostridium Difficile Infection: A Systematic Review and Meta-Analysis. Immunotherapy 8:5, pages 649-663.
Read now
Jennifer Steele, Jerlyn Sponseller, Diane Schmidt, Ocean Cohen & Saul Tzipori. (2013) Hyperimmune bovine colostrum for treatment of GI infections. Human Vaccines & Immunotherapeutics 9:7, pages 1565-1568.
Read now
Wlodzimierz Otto, Boguslaw Najnigier, Teodor Stelmasiak & Roy M. Robins-Browne. (2011) Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers. Scandinavian Journal of Gastroenterology 46:7-8, pages 862-868.
Read now

Articles from other publishers (54)

Alexa R. WeingardenCynthia W. Ko. (2024) Non-prescription Therapeutics. American Journal of Gastroenterology 119:1S, pages S7-S15.
Crossref
Camille Campidelli, Jean-François Bruxelle, Anne Collignon & Severine Péchiné. 2024. Updates on Clostridioides difficile in Europe. Updates on Clostridioides difficile in Europe 117 150 .
Dilara Islam, Nattaya Ruamsap, Rawiwan Imerbsin, Patchariya Khanijou, Siriphan Gonwong, Matthew D. Wegner, Annette McVeigh, Frédéric M. Poly, John M. Crawford, Brett E. Swierczewski, Robert W. Kaminski & Renee M. Laird. (2023) Bioactivity and efficacy of a hyperimmune bovine colostrum product- Travelan, against shigellosis in a non-Human primate model (Macaca mulatta). PLOS ONE 18:12, pages e0294021.
Crossref
Joshua Heuler, Harish Chandra & Xingmin Sun. (2023) Mucosal Vaccination Strategies against Clostridioides difficile Infection. Vaccines 11:5, pages 887.
Crossref
Elena Reigadas, Joffrey van Prehn, Marco Falcone, Fidelma Fitzpatrick, Maria J.G.T. Vehreschild, Ed J. Kuijper & Emilio Bouza. (2021) How to: prophylactic interventions for prevention of Clostridioides difficile infection. Clinical Microbiology and Infection 27:12, pages 1777-1783.
Crossref
Meinolf Ebbers, Christoph J. Hemmer, Brigitte Müller-Hilke & Emil C. Reisinger. (2020) Immunotherapy and vaccination against infectious diseases. Wiener klinische Wochenschrift 133:13-14, pages 714-720.
Crossref
Hans-Jürgen Heidebrecht, Ilias Lagkouvardos, Sandra Reitmeier, Claudia Hengst, Ulrich Kulozik & Michael W. Pfaffl. (2021) Alteration of Intestinal Microbiome of Clostridioides difficile-Infected Hamsters during the Treatment with Specific Cow Antibodies. Antibiotics 10:6, pages 724.
Crossref
Fanni Dembrovszky, Noémi Gede, Zsolt Szakács, Péter Hegyi, Szabolcs Kiss, Nelli Farkas, Zsolt Molnár, Marcell Imrei, Dóra Dohos & Zoltán Péterfi. (2020) Fecal Microbiota Transplantation May Be the Best Option in Treating Multiple Clostridioides difficile Infection: A Network Meta-Analysis. Infectious Diseases and Therapy 10:1, pages 201-211.
Crossref
Nicola Principi, Margherita Gnocchi, Martina Gagliardi, Alberto Argentiero, Cosimo Neglia & Susanna Esposito. (2020) Prevention of Clostridium difficile Infection and Associated Diarrhea: An Unsolved Problem. Microorganisms 8:11, pages 1640.
Crossref
Sarah E. Madoff, Mariana Urquiaga, Carolyn D. Alonso & Ciarán P. Kelly. (2020) Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials. Anaerobe 61, pages 102098.
Crossref
Hans-Jürgen Heidebrecht, William J Weiss, Mark Pulse, Anton Lange, Karina Gisch, Heike Kliem, Sacha Mann, Michael W. Pfaffl, Ulrich Kulozik & Christoph von Eichel-Streiber. (2019) Treatment and Prevention of Recurrent Clostridium difficile Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model. Toxins 11:2, pages 98.
Crossref
Shane Feeney, Sinead T. Morrin, Lokesh Joshi & Rita M. Hickey. 2018. Novel Proteins for Food, Pharmaceuticals and Agriculture. Novel Proteins for Food, Pharmaceuticals and Agriculture 291 314 .
Christiane Schmautz, Nadine Müller, Marlene Auer, Ines Ballweg, Michael W. Pfaffl & Heike Kliem. (2018) Immune cell counts and signaling in body fluids of cows vaccinated against Clostridium difficile. Journal of Biological Research-Thessaloniki 25:1.
Crossref
Yu. A. Shelygin, V. A. Aleshkin, M. A. Sukhina, A. Yu. Mironov, N. I. Briko, R. S. Kozlov, V. V. Zverev, S. I. Achkasov, O. V. Kovalishena, E. P. Selkova, A. L. Safin, T. A. Grenkova, I. L. Khalif, S. A. Frolov, V. N. Kashnikov & O. I. Sushkov. (2018) КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ НАЦИОНАЛЬНОЙ АССОЦИАЦИИ СПЕЦИАЛИСТОВ ПО КОНТРОЛЮ ИНФЕКЦИЙ, СВЯЗАННЫХ С ОКАЗАНИЕМ МЕДИЦИНСКОЙ ПОМОЩИ, И ОБЩЕРОССИЙСКОЙ ОБЩЕСТВЕННОЙ НЕКОММЕРЧЕСКОЙ ОРГАНИЗАЦИИ «АССОЦИАЦИЯ КОЛОПРОКТОЛОГОВ РОССИИ» ПО ДИАГНОСТИКЕ, ЛЕЧЕНИЮ И ПРОФИЛАКТИКЕ CLOSTRIDIUM DIFFICILE-АССОЦИИРОВАННОЙ ДИАРЕИ (CDI). Koloproktologia:3, pages 7-23.
Crossref
Hans-Jürgen Heidebrecht, Bernadette Kainz, Roland Schopf, Klaus Godl, Züleyha Karcier, Ulrich Kulozik & Beatrix Förster. (2018) Isolation of biofunctional bovine immunoglobulin G from milk- and colostral whey with mixed-mode chromatography at lab and pilot scale. Journal of Chromatography A 1562, pages 59-68.
Crossref
Beatrix Förster, Pui Khi Chung, Monique J. T. Crobach & Ed J. Kuijper. (2018) Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection. Frontiers in Microbiology 9.
Crossref
Laurien H. Ulfman, Jeanette H. W. Leusen, Huub F. J. Savelkoul, John O. Warner & R. J. Joost van Neerven. (2018) Effects of Bovine Immunoglobulins on Immune Function, Allergy, and Infection. Frontiers in Nutrition 5.
Crossref
Séverine Péchiné, Jean F. Bruxelle, Claire Janoir & Anne Collignon. (2018) Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection. Frontiers in Microbiology 9.
Crossref
Jean-François Bruxelle, Séverine Péchiné & Anne Collignon. 2018. Updates on Clostridium difficile in Europe. Updates on Clostridium difficile in Europe 197 225 .
Melanie L. Hutton, Bliss A. Cunningham, Kate E. Mackin, Shelley A. Lyon, Meagan L. James, Julian I. Rood & Dena Lyras. (2017) Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative. Scientific Reports 7:1.
Crossref
Richard L Nelson, Katie J Suda & Charlesnika T Evans. (2017) Antibiotic treatment for Clostridium difficile -associated diarrhoea in adults . Cochrane Database of Systematic Reviews 2017:3.
Crossref
Csaba Fehér, Alex Soriano & Josep Mensa. (2016) A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection. Infectious Diseases and Therapy 6:1, pages 1-35.
Crossref
Anshul Sood & Chetana Vaishnavi. (2016) Non-antibiotic management for Clostridium difficile infection . Journal of Gastrointestinal Infections 6:1, pages 3-11.
Crossref
M. Scott Harris, Deborah Hartman, Brenda R. Lemos, Emma C. Erlich, Sharon Spence, Sally Kennedy, Theadore Ptak, Ronald Pruitt, Severine Vermeire & Barbara S. Fox. (2016) AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial. Journal of Crohn's and Colitis 10:6, pages 631-640.
Crossref
Larry K. Kociolek & Dale N. Gerding. (2016) Breakthroughs in the treatment and prevention of Clostridium difficile infection. Nature Reviews Gastroenterology & Hepatology 13:3, pages 150-160.
Crossref
Kelsey Shields, Roger V. Araujo-Castillo, Thimmaiah G. Theethira, Carolyn D. Alonso & Ciaran P. Kelly. (2015) Recurrent Clostridium difficile infection: From colonization to cure. Anaerobe 34, pages 59-73.
Crossref
J.J. KellerE.J. Kuijper. (2015) Treatment of Recurrent and Severe Clostridium Difficile Infection . Annual Review of Medicine 66:1, pages 373-386.
Crossref
J. K. Sponseller, J. A. Steele, D. J. Schmidt, H. B. Kim, G. Beamer, X. Sun & S. Tzipori. (2014) Hyperimmune Bovine Colostrum as a Novel Therapy to Combat Clostridium difficile Infection. Journal of Infectious Diseases.
Crossref
Michael Simon, Stephanie Chervin & Stephen Brown. (2014) Polyclonal Antibody Therapies for Clostridium difficile Infection. Antibodies 3:4, pages 272-288.
Crossref
Dimitri M Drekonja. (2014) Clostridium difficile infection: current, forgotten and emerging treatment options . Journal of Comparative Effectiveness Research 3:5, pages 547-557.
Crossref
S.B. Debast, M.P. Bauer & E.J. Kuijper. (2014) European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection. Clinical Microbiology and Infection 20, pages 1-26.
Crossref
J. C. O’Horo, K. Jindai, B. Kunzer & N. Safdar. (2013) Treatment of recurrent Clostridium difficile infection: a systematic review. Infection 42:1, pages 43-59.
Crossref
Glenn S Tillotson & Karl WeissCiarán P KellySaurabh Sethi. 2013. Clostridium difficile : New Challenges for an Old Foe . Clostridium difficile : New Challenges for an Old Foe 34 45 .
Christina M Surawicz, Lawrence J Brandt, David G Binion, Ashwin N Ananthakrishnan, Scott R Curry, Peter H Gilligan, Lynne V McFarland, Mark Mellow & Brian S Zuckerbraun. (2013) Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. American Journal of Gastroenterology 108:4, pages 478-498.
Crossref
Katie Solomon. (2013) The host immune response to Clostridium difficile infection . Therapeutic Advances in Infectious Disease 1:1, pages 19-35.
Crossref
F. Karaahmet, S. Coban, O. Yuksel, Ö Başar & I. Yüksel. (2012) Letter: Clostridium difficile colitis in patients with ulcerative colitis . Alimentary Pharmacology & Therapeutics 37:2, pages 285-286.
Crossref
E. Mattila, P. Arkkila, P. S. Mattila, E. Tarkka, P. Tissari & V.‐J. Anttila. (2012) Rifaximin in the treatment of recurrent Clostridium difficile infection . Alimentary Pharmacology & Therapeutics 37:1, pages 122-128.
Crossref
Benjamin E. Stein, William B. GreenoughIIIIII & Simon C. Mears. (2013) Management and Prevention of Recurrent Clostridium Difficile Infection in Patients After Total Joint Arthroplasty . Geriatric Orthopaedic Surgery & Rehabilitation 3:4, pages 157-163.
Crossref
Eero Mattila, Raija Uusitalo–Seppälä, Maarit Wuorela, Laura Lehtola, Heimo Nurmi, Matti Ristikankare, Veikko Moilanen, Kimmo Salminen, Maaria Seppälä, Petri S. Mattila, Veli–Jukka Anttila & Perttu Arkkila. (2012) Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection. Gastroenterology 142:3, pages 490-496.
Crossref
Arvind Hettiarachchy, Navam Sato, Kenji Marshall & Maurice KannanHannu Korhonen & Susanna Rokka. 2011. Bioactive Food Proteins and Peptides. Bioactive Food Proteins and Peptides 49 96 .
Ethan Gough, Henna Shaikh & Amee R. Manges. (2011) Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection. Clinical Infectious Diseases 53:10, pages 994-1002.
Crossref
Richard L Nelson, Philippa Kelsey, Hayley Leeman, Naomi Meardon, Haymesh Patel, Kim Paul, Richard Rees, Ben Taylor, Elizabeth Wood & Rexanna Malakun. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Ciarán P. Kelly & Lorraine Kyne. (2011) The host immune response to Clostridium difficile. Journal of Medical Microbiology 60:8, pages 1070-1079.
Crossref
Christina M. Surawicz & Jacob Alexander. (2011) Treatment of refractory and recurrent Clostridium difficile infection. Nature Reviews Gastroenterology & Hepatology 8:6, pages 330-339.
Crossref
Claire M.F. van Nispen tot Pannerden, Annelies Verbon & Ernst J. Kuipers. (2011) Recurrent Clostridium difficile Infection. Drugs 71:7, pages 853-868.
Crossref
Allen Thomas Griffin & Forest Wayne Arnold. (2011) The Most Effective Treatments for Clostridium difficile Diarrhea. Infectious Diseases in Clinical Practice 19:3, pages 171-181.
Crossref
Greg Hussack & Jamshid Tanha. (2010) Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives. Toxins 2:5, pages 998-1018.
Crossref
THEODORE S. STEINER & RICHARD L. GUERRANT. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 1335 1351 .
M.P. Bauer, E.J. Kuijper & J.T. van Dissel. (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clinical Microbiology and Infection 15:12, pages 1067-1079.
Crossref
Martijn P Bauer, Jaap T van Dissel & Ed J Kuijper. (2009) Clostridium difficile: controversies and approaches to management. Current Opinion in Infectious Diseases 22:6, pages 517-524.
Crossref
John O’Horo & Nasia Safdar. (2009) The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review. International Journal of Infectious Diseases 13:6, pages 663-667.
Crossref
Martijn P. Bauer & Jaap T. van Dissel. (2009) Alternative strategies for Clostridium difficile infection. International Journal of Antimicrobial Agents 33, pages S51-S56.
Crossref
H.J. Korhonen & P. Marnila. 2009. Dairy-Derived Ingredients. Dairy-Derived Ingredients 269 289 .
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.